|Bid||0.7250 x 0|
|Ask||0.7300 x 0|
|Day's range||0.7250 - 0.7300|
|52-week range||0.5250 - 0.7300|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||42.65|
|Forward dividend & yield||N/A (N/A)|
|1y target est||0.74|
SINGAPORE (Aug 19): Regional healthcare provider Health Management International (HMI) on Monday night reported earnings fell 11% to RM13.5 million ($4.5 million), or 1.61 sen per share, for the 4Q19 ended June 30, down from RM15.2 million a year ago. Gross profit margin decreased to 33% from 34.4% the year before due to StarMed Specialist Centre (SSC), its new ambulatory care centre in Singapore which started operations in 1Q19. Other gains increased to RM2.9 million from RM0.9 million mainly due to higher foreign exchange gains of RM2.6 million recorded in 4Q19 compared to a year ago.
SINGAPORE (July 8): Shares in Health Management International (HMI) are up as high as 9.1% at 2.48pm to trade at 72 cents from its last close on July 4 of 66 cents. The price surge follows the group's announcement on July 5 that it has received a 73 cents per share privatisation offer from PanAsia Health, valuing the target at $611 million. PanAsia says the acquisition will allow it to invest in a reputable private healthcare provider with a regional presence in Singapore, Malaysia and Indonesia.
Early last year, market research firm Frost and Sullivan predicted that the Asia-Pacific healthcare industry is going to grow at 11.1 percent in 2018 driven by an increasing adoption of technology, innovative healthcare access and delivery of care outside of traditional hospital settings. Concurrently, Singapore Exchange (SGX) also released a market update identifying the five largest healthcare companies listed on the local bourse in terms of market capitalisation.